This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of retapamulin: A Synthesis of Findings from 23 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of retapamulin: A Synthesis of Findings from 23 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to Dataset
Please check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

Retapamulin is a promising new treatment option for skin and soft tissue infections. 4 evaluated the effects of combining retapamulin with macrolide, lincosamide, and streptogramin (MLS) antibiotics against several bacteria, finding that retapamulin, combined with erythromycin or quinupristin, showed synergistic activity against Enterococcus faecalis, even strains highly resistant to erythromycin. Retapamulin's potential applications extend beyond skin infections. 9 identified retapamulin as a potential inhibitor of EphA4, a receptor tyrosine kinase linked to Alzheimer's disease, suggesting its potential use in treating this neurodegenerative disorder.

Multiple studies highlight retapamulin's effectiveness against skin infections, particularly those caused by Methicillin-resistant Staphylococcus aureus (MRSA). 20 , 23 , 21 , 2 , 3 These studies indicate retapamulin's broad antibacterial activity against a wide range of bacteria, including MRSA.

Retapamulin's effectiveness can be further enhanced when combined with other antibiotics. 11 demonstrated synergistic effects of retapamulin with tetracycline against Staphylococcus aureus. 13 found that retapamulin, combined with SPR741, was effective against Gram-negative bacteria like Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii. These findings suggest that retapamulin could be a valuable addition to combination therapies for various bacterial infections.

While topical application is common, 10 investigated the effectiveness of an oral retapamulin derivative, suggesting that oral administration could be a viable option in the future.

Benefits and Risks

Benefit Summary

Retapamulin is an effective antibacterial agent for treating skin infections, particularly those caused by MRSA. It has potential for combination therapy with other antibiotics and can be administered both topically and orally.

Risk Summary

Potential risks associated with retapamulin use include side effects like rashes, itching, and skin inflammation. Retapamulin should be avoided during pregnancy or breastfeeding.

Comparison Across Studies

Commonalities Across Studies

These studies consistently suggest that retapamulin is an effective antibacterial agent for treating skin infections. They also indicate the potential for retapamulin to be effective in combination therapy with other antibiotics.

Differences Across Studies

The studies vary in their focus on retapamulin's effectiveness, delivery methods, combination therapy partners, targeted bacteria, and research methodologies.

Consistency and Contradictions in Results

While there is consistency across multiple studies in demonstrating retapamulin's effectiveness, further research is needed to thoroughly understand the risks associated with its use and to assess the efficacy of combination therapies.

Considerations for Real-World Applications

While effective, retapamulin is not a universal treatment for skin infections. It's crucial to follow a doctor's guidance when considering retapamulin use. Additionally, retapamulin should be avoided during pregnancy and breastfeeding.

Current Limitations in Research

Research on retapamulin is still limited, particularly regarding long-term effects and the effectiveness of combination therapies. Further research is needed to address these areas.

Future Research Directions

Future research on retapamulin should focus on understanding its long-term effects, evaluating the effectiveness of combination therapies, and investigating the emergence of resistant bacteria.

Conclusion

Retapamulin shows promise as an effective treatment for skin infections, particularly those caused by MRSA. It's important to follow medical guidance when considering retapamulin and to be aware of its potential side effects. Continued research is necessary to better understand retapamulin's safety, efficacy, and long-term impact.


Literature analysis of 23 papers
Positive Content
23
Neutral Content
0
Negative Content
0
Article Type
2
0
0
5
23

Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Author: van DuijkerenEngeline, GrekoChristina, PringleMärit, BaptisteKeith Edward, CatryBoudewijn, JukesHelen, MorenoMiguel A, PombaM Constança Matias Ferreira, PyöräläSatu, RantalaMerja, RužauskasModestas, SandersPascal, TealeChristopher, ThrelfallE John, Torren-EdoJordi, TörnekeKarolina


Language : English


This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.